- Establishment Labs ( NASDAQ: ESTA ) expects Q4 revenue to be in the range of $43.3M to $44.3M, representing growth of 23% to 25% Y/Y vs consensus of $42.81M , growth in the fourth quarter is expected to be 27% to 29%.
- Fiscal year 2022 revenue is expected to be in the range of $161.2M to $162.2M, representing growth of 27% to 28% Y/Y vs consensus of $160.49M , growth for fiscal year 2022 is expected to be 31% to 32%.
- CEO update: “We are particularly proud of the strong finish to the year, as we delivered better than 30% constant currency growth in 2022. Along with continued solid underlying growth, major catalysts in 2023 include the expected expansion of Motiva Implants into new geographic markets and the global rollout of Mia Femtech™. This looks to be another strong year for ESTA.”
For further details see:
Establishment Labs reports prelim 4Q and fiscal 2022 revenue above consensus